Image: PATH global health [CC BY 2.0] via Flickr
University College London and the University of Oxford will take the lead in a £7-million vaccine development centre set up to improve responses to deadly pandemics such as swine flu and Ebola.
Vax-Hub will bring together academia, drug companies and policymakers to improve the development and manufacturing of vaccines with potential to be used in low and middle-income countries. It will funded by UK aid money from the Department of Health and Social Care, through a grant managed by the Engineering and Physical Sciences Research Council.
The 25 partners include Public Health England, the University of Leeds, Imperial College London, the London School of Hygiene and Tropical Medicine, and the pharmaceutical companies AstraZeneca and Pfizer.
This article is only available to Research Professional News subscribers. If you are a subscriber you can read the article in full on researchprofessional.com
Pivot-RP users can log in and view the article via this link.